-
1
-
-
0033012447
-
Classic disease revisited: Hypokalemic paralysis
-
Ahlawat SK, Sadchev A. Classic disease revisited: hypokalemic paralysis. Postgrad Med J 1999; 75:193-197.
-
(1999)
Postgrad Med J
, vol.75
, pp. 193-197
-
-
Ahlawat, S.K.1
Sadchev, A.2
-
2
-
-
0030992784
-
Hypokalemic periodic paralysis: An autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel
-
Lapie P, Lory P, Fontaine B. Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscul Disord 1997; 7:234-240.
-
(1997)
Neuromuscul Disord
, vol.7
, pp. 234-240
-
-
Lapie, P.1
Lory, P.2
Fontaine, B.3
-
4
-
-
0040565182
-
Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current
-
Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J, et al. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A 2000; 97:9549-9554.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 9549-9554
-
-
Jurkat-Rott, K.1
Mitrovic, N.2
Hang, C.3
Kouzmekine, A.4
Iaizzo, P.5
Herzog, J.6
-
5
-
-
0036211354
-
Enhanced inactivation and pH sensitivity of Na+ channel mutations causing hypokalemic periodic paralysis type II
-
Kuzmenkin A, Muncan V, Jurkat-Rott K, Hang C, Lerche H, Lehmann-Horn F, Mitrovic N. Enhanced inactivation and pH sensitivity of Na+ channel mutations causing hypokalemic periodic paralysis type II. Brain 2002; 125:835-843.
-
(2002)
Brain
, vol.125
, pp. 835-843
-
-
Kuzmenkin, A.1
Muncan, V.2
Jurkat-Rott, K.3
Hang, C.4
Lerche, H.5
Lehmann-Horn, F.6
Mitrovic, N.7
-
6
-
-
0034554770
-
The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation
-
Struyk AF, Scoggan KA, Bulman DE, Cannon SC. The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation. J Neurosci 2000; 20:8610-8617.
-
(2000)
J Neurosci
, vol.20
, pp. 8610-8617
-
-
Struyk, A.F.1
Scoggan, K.A.2
Bulman, D.E.3
Cannon, S.C.4
-
7
-
-
0028905566
-
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
-
Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80:805-811.
-
(1995)
Cell
, vol.80
, pp. 805-811
-
-
Wang, Q.1
Shen, J.2
Splawski, I.3
Atkinson, D.4
Li, Z.5
Robinson, J.L.6
-
8
-
-
0003096674
-
Cardiac conduction defects associate with mutations in SCN5A
-
Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeek M, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999; 23:20-21.
-
(1999)
Nat Genet
, vol.23
, pp. 20-21
-
-
Schott, J.J.1
Alshinawi, C.2
Kyndt, F.3
Probst, V.4
Hoorntje, T.M.5
Hulsbeek, M.6
-
9
-
-
0037154288
-
Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block
-
Wang DW, Viswanathan PC, Balser JR, George AL, Benson DW. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation 2002; 105:341-346.
-
(2002)
Circulation
, vol.105
, pp. 341-346
-
-
Wang, D.W.1
Viswanathan, P.C.2
Balser, J.R.3
George, A.L.4
Benson, D.W.5
-
10
-
-
0037469197
-
Paramyotonia congenita with an SCN4A mutation affecting cardiac repolarization
-
Pereon Y, Lande G, Demolombe S, Tich SNT, Sternberg D, Le Marec H, David A. Paramyotonia congenita with an SCN4A mutation affecting cardiac repolarization. Neurology 2003; 60:340-342.
-
(2003)
Neurology
, vol.60
, pp. 340-342
-
-
Pereon, Y.1
Lande, G.2
Demolombe, S.3
Tich, S.N.T.4
Sternberg, D.5
Le Marec, H.6
David, A.7
-
11
-
-
0036147769
-
Recognising signs of danger: EKG changes resulting from an abnormal serum potassium concentration
-
Webster A, BradyW,Morris F.Recognising signs of danger: EKG changes resulting from an abnormal serum potassium concentration. Emerg Med J 2002; 19:74-77.
-
(2002)
Emerg Med J
, vol.19
, pp. 74-77
-
-
Webster, A.1
BradyW2
Morris, F.3
-
12
-
-
33745786609
-
Thyrotoxic periodic paralysis: A diagnostic challenge
-
Kung AW. Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 2006; 91:2490-2495.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 2490-2495
-
-
Kung, A.W.1
-
13
-
-
0141457198
-
Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis
-
Hsu YJ, Lin YF, Chau T, Liou JT, Kuo SW, Lin SH. Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis. Am J Med Sci 2003; 326:128-132.
-
(2003)
Am J Med Sci
, vol.326
, pp. 128-132
-
-
Hsu, Y.J.1
Lin, Y.F.2
Chau, T.3
Liou, J.T.4
Kuo, S.W.5
Lin, S.H.6
-
15
-
-
0019831369
-
Family Periodic Paralysis with Hypokalaemia
-
Johnsen T. Family Periodic Paralysis with Hypokalaemia. Danish Medical Bulletin 1981; 28:1-27.
-
(1981)
Danish Medical Bulletin
, vol.28
, pp. 1-27
-
-
Johnsen, T.1
-
16
-
-
33846443989
-
Long QT syndrome in a patient with allergic rhinoconjunctivitis and auto-immune diabetes: Focus on the choice of anti-H1 drugs
-
Moneret-Vautrin DA, de Chillou C, Codreanu A. Long QT syndrome in a patient with allergic rhinoconjunctivitis and auto-immune diabetes: focus on the choice of anti-H1 drugs. Allerg Immunol (Paris) 2006; 38:347-350.
-
(2006)
Allerg Immunol (Paris)
, vol.38
, pp. 347-350
-
-
Moneret-Vautrin, D.A.1
de Chillou, C.2
Codreanu, A.3
|